These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 15165749)

  • 1. Peroxisome proliferator-activated receptor gamma in diabetes and metabolism.
    Rangwala SM; Lazar MA
    Trends Pharmacol Sci; 2004 Jun; 25(6):331-6. PubMed ID: 15165749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PPAR gamma gene--a review.
    Janani C; Ranjitha Kumari BD
    Diabetes Metab Syndr; 2015; 9(1):46-50. PubMed ID: 25450819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator-activated receptor gamma: A key regulator of adipogenesis and systemic insulin sensitivity.
    Spiegelman BM
    Eur J Med Res; 1997 Nov; 2(11):457-64. PubMed ID: 9385114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive messenger ribonucleic acid profiling reveals that peroxisome proliferator-activated receptor gamma activation has coordinate effects on gene expression in multiple insulin-sensitive tissues.
    Way JM; Harrington WW; Brown KK; Gottschalk WK; Sundseth SS; Mansfield TA; Ramachandran RK; Willson TM; Kliewer SA
    Endocrinology; 2001 Mar; 142(3):1269-77. PubMed ID: 11181544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Peroxisome proliferator activated receptors PPARs: their role in carbohydrate and lipid metabolism].
    Andrééva-Gatéva P
    Ann Biol Clin (Paris); 2003; 61(3):295-303. PubMed ID: 12805006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Molecular nutrition, role of the PPAR system in lipidic metabolism and its importance in obesity and diabetes mellitus].
    Uauy R; Martínez JI; Rojas CV
    Rev Med Chil; 2000 Apr; 128(4):437-46. PubMed ID: 10962863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator-activated receptors as molecular targets for drug therapy.
    Sridhar GR
    J Assoc Physicians India; 2003 Jan; 51():49-52. PubMed ID: 12693455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxisome proliferator-activated receptor gamma and metabolic disease.
    Willson TM; Lambert MH; Kliewer SA
    Annu Rev Biochem; 2001; 70():341-67. PubMed ID: 11395411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PPAR gamma, 10 years later.
    Lazar MA
    Biochimie; 2005 Jan; 87(1):9-13. PubMed ID: 15733730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism by which a novel non-thiazolidinedione peroxisome proliferator-activated receptor gamma agonist, FK614, ameliorates insulin resistance in Zucker fatty rats.
    Minoura H; Takeshita S; Kimura C; Hirosumi J; Takakura S; Kawamura I; Seki J; Manda T; Mutoh S
    Diabetes Obes Metab; 2007 May; 9(3):369-78. PubMed ID: 17391165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [PPAR gamma--the master of thrifty genes].
    Chang YS; Fang FD
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Jun; 24(3):315-20. PubMed ID: 12905643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PPARs and the complex journey to obesity.
    Evans RM; Barish GD; Wang YX
    Nat Med; 2004 Apr; 10(4):355-61. PubMed ID: 15057233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisome proliferator-activated receptor gamma as a drug target in the pathogenesis of insulin resistance.
    Guo L; Tabrizchi R
    Pharmacol Ther; 2006 Jul; 111(1):145-73. PubMed ID: 16305809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PPAR agonists: multimodal drugs for the treatment of type-2 diabetes.
    Gross B; Staels B
    Best Pract Res Clin Endocrinol Metab; 2007 Dec; 21(4):687-710. PubMed ID: 18054742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferator-activated receptor gamma and the regulation of adipocyte function: lessons from human genetic studies.
    Gurnell M
    Best Pract Res Clin Endocrinol Metab; 2005 Dec; 19(4):501-23. PubMed ID: 16311214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pioglitazone: mechanism of action.
    Smith U
    Int J Clin Pract Suppl; 2001 Sep; (121):13-8. PubMed ID: 11594239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weight-loss-associated induction of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma correlate with reduced atherosclerosis and improved cardiovascular function in obese insulin-resistant mice.
    Verreth W; De Keyzer D; Pelat M; Verhamme P; Ganame J; Bielicki JK; Mertens A; Quarck R; Benhabilès N; Marguerie G; Mackness B; Mackness M; Ninio E; Herregods MC; Balligand JL; Holvoet P
    Circulation; 2004 Nov; 110(20):3259-69. PubMed ID: 15533870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of PPARs in the regulation of obesity-related insulin sensitivity and inflammation.
    Moller DE; Berger JP
    Int J Obes Relat Metab Disord; 2003 Dec; 27 Suppl 3():S17-21. PubMed ID: 14704738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the orphan nuclear receptor Rev-Erb alpha in adipocyte differentiation and function.
    Laitinen S; Fontaine C; Fruchart JC; Staels B
    Biochimie; 2005 Jan; 87(1):21-5. PubMed ID: 15733732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of PPARgamma ligands on the adipose tissue in insulin resistance.
    Hammarstedt A; Andersson CX; Rotter Sopasakis V; Smith U
    Prostaglandins Leukot Essent Fatty Acids; 2005 Jul; 73(1):65-75. PubMed ID: 15936183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.